focus -WSS

focus

author：fashion 2025-09-30 00:03:02 - browse：213

Launching your first clinical trial is the type of announcement most biotech executives eagerly anticipate, hoping to celebrate with employees. But for Celsius Therapeutics CEO Tariq Kassum, it’s proving to be more difficult than he anticipated.

That’s because in recent days, Celsius, based in Cambridge, Mass., has been forced to conduct a round of layoffs, sources told STAT. Kassum confirmed around 75% of Celsius’ 40-person team had been laid off, and disclosed that the biotech has also been quietly paring back its pipeline this year. It shut down almost all early-stage research projects, including pausing all of its cancer drug work, in order to conserve enough cash for the Phase 1 trial it announced this week.

“It’s an incredibly bittersweet moment.… The cognitive dissonance there is just really, really hard,” Kassum told STAT. “But I do think that you’re seeing a lot of other companies doing what we are, which is, as painful as it is, to focus on the nearest term value drivers, the things that can get to patients the quickest, and make the painful decisions that allow you to live to fight another day.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： State Dept. review finds Biden bears some blame for Afghanistan failures
Next article： Leukemia patients are helped by Syndax's new type of therapy

WSS

Petition to FDA: Get the lead out of consumer hair dyes

Why ADHD is under

Americans' trust in science, scientist continues decline: Report

Patients' immediate access to test results puts radiologists in a bind

SCOTUS to consider access to abortion pill mifepristone

Supreme Court wrestles with OxyContin maker's bankruptcy deal

entertainment

focus

explore

Wildfire smoke exposes gaps in outdoor worker protections

Sanofi says it has 12 blockbusters on the way. Will investors believe it?

In age of alternative facts, a scholarly course on calling out crap

N.Y. state detects polio case, first in the U.S. since 2013

Trump demands the U.S. pay no more for drugs than other countries … again

SCOTUS to consider access to abortion pill mifepristone

Drug repurposing or repositioning? The language matters

DOJ reversal could clear way for Carroll's 1st lawsuit against Trump to proceed

Medical leaders decry Supreme Court decision on affirmative action

Living with Fabry disease, a condition that causes chronic pain

knowledge

Why sickle cell disease is getting the first CRISPR treatment

FDA needs staff influx to meet gene therapy needs, Marks says

The woman behind the Dana Farber

Teach medical students about patients with intellectual disabilities

STAT Event – Decoding Clinical Trials: Venture Capitalists Talk Early Biotech R&D

Insurance companies sue energy corporation after it was blamed for helping start Colorado wildfire

hotspot

hotspot

focus

explore